We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
In 2016, Greg joined the Biotechnology Innovation Organization (BIO), where he leads several infectious diseases policy issues, including antimicrobial resistance and vaccine policy.
Greg Frank has a research background in immunology, where he trained at the University of Pittsburgh studying viral infections of the eye. In 2010 he went on to pursue his postdoctoral training at the National Institutes of Allergy & Infectious Diseases (NIAID) Laboratory of Viral Diseases (LVD), researching the immune response to influenza infection.
Greg transitioned into science policy through a 2013 fellowship with the Federation of American Societies for Experimental Biology (FASEB), where he helped develop a best practice document on mitigating the risk of animal rights extremism. In 2014, Greg then joined the Infectious Diseases Society of America (IDSA) to lead their science and diagnostic policies. At IDSA he worked on issues that included challenges confronting the infectious disease physician-scientist workforce, dual use research of concern, and policies to drive the development and clinical integration of rapid infectious disease diagnostics.
This speaker's sessions: